BNJ Biopharma

South Korea Founded: 2021 • Age: 5 yrs Acquired By The Invention Lab
AI-based anti-cancer drugs are developed using tumor diversity data.
Request Access

About BNJ Biopharma

BNJ Biopharma is a company based in South Korea founded in 2021 by Jae-June Dong was acquired by The Invention Lab in December 2023.. BNJ Biopharma operates in a competitive market with competitors including Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others.

  • Headquarter South Korea
  • Founders Jae-June Dong
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    The Invention Lab

    (Dec 08, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of BNJ Biopharma

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in BNJ Biopharma

BNJ Biopharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include The Invention Lab. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
The Invention Lab is recognized as a startup accelerator and seed investment firm.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by BNJ Biopharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - BNJ Biopharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Bnj Biopharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of BNJ Biopharma

BNJ Biopharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Enzene Biosciences, Hybio Pharmaceutical, Suanfarma, Nephron Pharmaceuticals and AmbioPharm, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Company specializing in development of Biosimilars
domain founded_year HQ Location
Polypeptide drugs and APIs are developed and manufactured.
domain founded_year HQ Location
Generics, nutraceuticals, and APIs are developed by Suanfarma.
domain founded_year HQ Location
Sterile pharmaceutical products are manufactured and contract services are provided.
domain founded_year HQ Location
CDMO and analytical services for peptide development are provided.
domain founded_year HQ Location
APIs and finished dosage forms are developed and manufactured.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Bnj Biopharma

Frequently Asked Questions about BNJ Biopharma

When was BNJ Biopharma founded?

BNJ Biopharma was founded in 2021.

Where is BNJ Biopharma located?

BNJ Biopharma is headquartered in South Korea.

Who is the current CEO of BNJ Biopharma?

Jae-June Dong is the current CEO of BNJ Biopharma. They have also founded this company.

What does BNJ Biopharma do?

BNJ Biopharma was founded in 2021 in South Korea as an AI-based drug development company. Focus is placed on designing anti-cancer drugs through analysis of tumor diversity data. Seed funding was obtained from INNOCUVE, with additional investment recently secured from The Invention Lab. Operations center on biotechnology and pharmaceutical innovation in the region.

Who are the top competitors of BNJ Biopharma?

BNJ Biopharma's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.

Who are BNJ Biopharma's investors?

BNJ Biopharma has 1 investor. Key investors include The Invention Lab.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available